Please assess the completion status of the following clinical trial:

Trial Title: Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. A diagnosis of dyslipidemia (non-HDL-C \>130 mg/dL and Triglycerides \> or equal to 150 mg/dL and \< or equal to 500 mg/dL).~2. Subject may be currently on a statin or other lipid-lowering therapy but must be willing and able to washout for 8 weeks if on a fibrate or high-dose niacin, 6 weeks if on a statin or low-dose niacin per day, or 4 weeks if on a bile acid sequestrant, ezetimibe, or \>1000 mg of fish oil per day.~3. Other inclusion criteria might apply~Exclusion Criteria:~1. TGs \> 500 mg/dL.~2. History of coronary heart disease (CHD), transient ischemic attacks, stroke or revascularization procedure in the six months prior.~3. Presence of an aortic aneurysm or resection of an aortic aneurysm within six months.~4. Poorly controlled diabetes mellitus (glycosylated hemoglobin \>8.0% )or diabetes mellitus requiring insulin therapy.~5. Known lipoprotein lipase impairment or deficiency or Apo C-II deficiency or familial dysbetalipoproteinemia.~6. History of pancreatitis.~7. Known allergy or sensitivity to statins or fibrates.~8. Poorly controlled hypertension.~9. Other exclusion criteria might apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LCP-AtorFen (Type: EXPERIMENTAL): LCP-AtorFen 40/100mg fixed-dose combination tablet of 40mg atorvastatin and 145mg fenofibrate for treatment of mixed dyslipidemia
- atorvastatin (Type: ACTIVE_COMPARATOR): atorvastatin 40mg tablet (Lipitor), as an adjunct to diet and exercise for treatment of mixed dyslipidemia
- fenofibrate (Type: ACTIVE_COMPARATOR): fenofibrate 145mg tablet (Tricor), as an adjunct to diet and exercise for treatment of mixed dyslipidemia

Based on this trial design, predict the completion outcome and termination type (if applicable).